Prosecution Insights
Last updated: October 04, 2026

Zeakal Inc.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Zeakal Inc. currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This 1 pending office action is being handled by 1 distinct examiner within 1 distinct art unit. The data indicates a narrow and specific focus for the company's current patent office interactions in this technical domain.

The busiest examiner for the portfolio is REDDEN, KAREN M, who is assigned the pending action. As the only distinct examiner with a pending case, REDDEN, KAREN M manages the active prosecution for Zeakal Inc. This alignment suggests a streamlined prosecution environment at this time. For practitioners, this means all current activity is confined to the 1 distinct art unit and the distinct examiner.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
REDDEN, KAREN M 1 88.4% -21.5%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18862834 METHODS AND COMPOSITIONS FOR MODIFYING SEED COMPOSITION REDDEN, KAREN M —

Top Art Units

Art UnitApps
1661 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18862834 METHODS AND COMPOSITIONS FOR MODIFYING SEED COMPOSITION REDDEN, KAREN M 1661 §103 Non-Final OA — Pending Nov 04, 2024

Managing Zeakal Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month